Early research (Phase 1)UnknownNCT04961632
What this trial is testing
Dose-determining and Dose-confirmatory Study to Investigate the Optimal Dose of Tamoxifen in Breast Cancer Patients According to Genotype Status of TCF20 rs932376
Who this might be right for
Breast Cancer
National Cancer Centre, Singapore 75